Las Vegas Sands Interest Paid increased by 48.3% to $212.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.8%, from $246.00M to $212.00M. Over 3 years (FY 2022 to FY 2025), Interest Paid shows an upward trend with a 5.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $50.00M | $244.00M | $226.00M | $52.00M | $250.00M | $86.00M | $296.00M | $95.00M | $279.00M | $76.00M | $260.00M | $94.00M | $209.00M | $87.00M | $246.00M | $117.00M | $204.00M | $143.00M | $212.00M |
| QoQ Change | — | +388.0% | -7.4% | -77.0% | +380.8% | -65.6% | +244.2% | -67.9% | +193.7% | -72.8% | +242.1% | -63.8% | +122.3% | -58.4% | +182.8% | -52.4% | +74.4% | -29.9% | +48.3% |
| YoY Change | — | — | — | +4.0% | +2.5% | — | +31.0% | +82.7% | +11.6% | -11.6% | -12.2% | -1.1% | -25.1% | +14.5% | -5.4% | +24.5% | -2.4% | +64.4% | -13.8% |